Cargando…
A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients
Carcinomatous meningitis (CM) is a critical issue for physicians. However, no study has reported a simple and useful diagnostic or predictive marker for CM. This study aimed to elucidate the potential markers for diagnosing CM derived from cerebrospinal fluid (CSF). We retrospectively enrolled 78 lu...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036056/ https://www.ncbi.nlm.nih.gov/pubmed/33832119 http://dx.doi.org/10.1097/MD.0000000000025367 |
_version_ | 1783676826062684160 |
---|---|
author | Ogawa, Yukari Saraya, Takeshi Noda, Akinari Kurokawa, Nozomi Sakuma, Sho Aso, Kaori Mikura, Sunao Oda, Miku Ishida, Manabu Honda, Kojiro Nakamoto, Keitaro Tamura, Masaki Takata, Saori Ishii, Haruyuki Takizawa, Hajime |
author_facet | Ogawa, Yukari Saraya, Takeshi Noda, Akinari Kurokawa, Nozomi Sakuma, Sho Aso, Kaori Mikura, Sunao Oda, Miku Ishida, Manabu Honda, Kojiro Nakamoto, Keitaro Tamura, Masaki Takata, Saori Ishii, Haruyuki Takizawa, Hajime |
author_sort | Ogawa, Yukari |
collection | PubMed |
description | Carcinomatous meningitis (CM) is a critical issue for physicians. However, no study has reported a simple and useful diagnostic or predictive marker for CM. This study aimed to elucidate the potential markers for diagnosing CM derived from cerebrospinal fluid (CSF). We retrospectively enrolled 78 lung cancer patients with suspected CM during the clinical course, including 42 CM and 36 non-CM patients. We compared the clinical and CSF findings, including carcinoembryonic antigen (CEA), between CM and non-CM patients, and explored the diagnostic markers for early identification of CM as well as the contributing factors for mortality. On CSF analysis, with cutoff values of CEA ≥5 ng/ml, total protein (TP) in CSF ≥45 g/dl, and total cell count (TCC) ≥7 cells/μL, the sensitivity, specificity, and area under the curve (AUC) for CM were 85.7%, 84.6%, and 0.887 (95% CI: 0.758–1.0, P < .001); 80.5%, 69.4%, and 0.755 (95% CI: 0.646–0.865, P < .001); and 56.1%, 100%, and 0.817 (95% CI: 0.722–0.912, P < .001), respectively. TP levels in CSF ≥the patients’ age had a sensitivity, specificity, and an AUC of 48.8%, 77.8%, and 0.633 (95% CI: 0.722–0.912, P = .045) for CM, respectively. Among CM patients, patients with ‘TP in CSF (>patients’ age)” (n = 19, P = .008) showed significantly shorter 90-day survival probability than the residual patients (n = 20). None of the CSF parameters could predict the risk of mortality on Cox regression analysis. The cutoff value of CEA ≥5 ng/ml in CSF is a simple and useful method with a high diagnostic value for CM diagnosis, but not a suitable predicting factor for mortality. ‘TP in CSF >patients’ age” might be a novel factor for assessing short-term mortality. |
format | Online Article Text |
id | pubmed-8036056 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-80360562021-04-13 A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients Ogawa, Yukari Saraya, Takeshi Noda, Akinari Kurokawa, Nozomi Sakuma, Sho Aso, Kaori Mikura, Sunao Oda, Miku Ishida, Manabu Honda, Kojiro Nakamoto, Keitaro Tamura, Masaki Takata, Saori Ishii, Haruyuki Takizawa, Hajime Medicine (Baltimore) 6700 Carcinomatous meningitis (CM) is a critical issue for physicians. However, no study has reported a simple and useful diagnostic or predictive marker for CM. This study aimed to elucidate the potential markers for diagnosing CM derived from cerebrospinal fluid (CSF). We retrospectively enrolled 78 lung cancer patients with suspected CM during the clinical course, including 42 CM and 36 non-CM patients. We compared the clinical and CSF findings, including carcinoembryonic antigen (CEA), between CM and non-CM patients, and explored the diagnostic markers for early identification of CM as well as the contributing factors for mortality. On CSF analysis, with cutoff values of CEA ≥5 ng/ml, total protein (TP) in CSF ≥45 g/dl, and total cell count (TCC) ≥7 cells/μL, the sensitivity, specificity, and area under the curve (AUC) for CM were 85.7%, 84.6%, and 0.887 (95% CI: 0.758–1.0, P < .001); 80.5%, 69.4%, and 0.755 (95% CI: 0.646–0.865, P < .001); and 56.1%, 100%, and 0.817 (95% CI: 0.722–0.912, P < .001), respectively. TP levels in CSF ≥the patients’ age had a sensitivity, specificity, and an AUC of 48.8%, 77.8%, and 0.633 (95% CI: 0.722–0.912, P = .045) for CM, respectively. Among CM patients, patients with ‘TP in CSF (>patients’ age)” (n = 19, P = .008) showed significantly shorter 90-day survival probability than the residual patients (n = 20). None of the CSF parameters could predict the risk of mortality on Cox regression analysis. The cutoff value of CEA ≥5 ng/ml in CSF is a simple and useful method with a high diagnostic value for CM diagnosis, but not a suitable predicting factor for mortality. ‘TP in CSF >patients’ age” might be a novel factor for assessing short-term mortality. Lippincott Williams & Wilkins 2021-04-09 /pmc/articles/PMC8036056/ /pubmed/33832119 http://dx.doi.org/10.1097/MD.0000000000025367 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | 6700 Ogawa, Yukari Saraya, Takeshi Noda, Akinari Kurokawa, Nozomi Sakuma, Sho Aso, Kaori Mikura, Sunao Oda, Miku Ishida, Manabu Honda, Kojiro Nakamoto, Keitaro Tamura, Masaki Takata, Saori Ishii, Haruyuki Takizawa, Hajime A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients |
title | A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients |
title_full | A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients |
title_fullStr | A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients |
title_full_unstemmed | A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients |
title_short | A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients |
title_sort | simple method for discrimination of carcinomatous meningitis using cea, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients |
topic | 6700 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036056/ https://www.ncbi.nlm.nih.gov/pubmed/33832119 http://dx.doi.org/10.1097/MD.0000000000025367 |
work_keys_str_mv | AT ogawayukari asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT sarayatakeshi asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT nodaakinari asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT kurokawanozomi asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT sakumasho asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT asokaori asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT mikurasunao asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT odamiku asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT ishidamanabu asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT hondakojiro asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT nakamotokeitaro asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT tamuramasaki asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT takatasaori asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT ishiiharuyuki asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT takizawahajime asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT ogawayukari simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT sarayatakeshi simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT nodaakinari simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT kurokawanozomi simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT sakumasho simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT asokaori simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT mikurasunao simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT odamiku simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT ishidamanabu simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT hondakojiro simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT nakamotokeitaro simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT tamuramasaki simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT takatasaori simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT ishiiharuyuki simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients AT takizawahajime simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients |